Switch theme
Sign up to access all valuation multiples
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
1993
4.3K+
LTM Revenue $544M
LTM EBITDA $114M
$2.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
UFP Technologies has a last 12-month revenue (LTM) of $544M and a last 12-month EBITDA of $114M.
In the most recent fiscal year, UFP Technologies achieved revenue of $504M and an EBITDA of $95.8M.
UFP Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See UFP Technologies valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $544M | XXX | $504M | XXX | XXX | XXX |
| Gross Profit | $156M | XXX | $147M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA | $114M | XXX | $95.8M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $90.8M | XXX | $84.5M | XXX | XXX | XXX |
| EBIT Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $62.9M | XXX | $59.0M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $176M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, UFP Technologies's stock price is $234.
UFP Technologies has current market cap of $1.8B, and EV of $2.0B.
See UFP Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.0B | $1.8B | XXX | XXX | XXX | XXX | $8.97 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, UFP Technologies has market cap of $1.8B and EV of $2.0B.
UFP Technologies's trades at 3.9x EV/Revenue multiple, and 20.8x EV/EBITDA.
Equity research analysts estimate UFP Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
UFP Technologies has a P/E ratio of 28.7x.
See valuation multiples for UFP Technologies and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBITDA | 17.5x | XXX | 20.8x | XXX | XXX | XXX |
| EV/EBIT | 21.9x | XXX | 23.5x | XXX | XXX | XXX |
| EV/Gross Profit | 12.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 28.7x | XXX | 30.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 34.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialUFP Technologies's last 12 month revenue growth is 13%
UFP Technologies's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $14K for the same period.
UFP Technologies's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
UFP Technologies's rule of X is 54% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for UFP Technologies and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 34% | XXX | XXX | XXX |
| Rule of 40 | 30% | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 54% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $14K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
UFP Technologies acquired XXX companies to date.
Last acquisition by UFP Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . UFP Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was UFP Technologies founded? | UFP Technologies was founded in 1993. |
| Where is UFP Technologies headquartered? | UFP Technologies is headquartered in United States of America. |
| How many employees does UFP Technologies have? | As of today, UFP Technologies has 4.3K+ employees. |
| Who is the CEO of UFP Technologies? | UFP Technologies's CEO is Mr. R. Jeffrey Bailly. |
| Is UFP Technologies publicy listed? | Yes, UFP Technologies is a public company listed on NAS. |
| What is the stock symbol of UFP Technologies? | UFP Technologies trades under UFPT ticker. |
| When did UFP Technologies go public? | UFP Technologies went public in 1993. |
| Who are competitors of UFP Technologies? | Similar companies to UFP Technologies include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of UFP Technologies? | UFP Technologies's current market cap is $1.8B |
| What is the current revenue of UFP Technologies? | UFP Technologies's last 12 months revenue is $544M. |
| What is the current revenue growth of UFP Technologies? | UFP Technologies revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of UFP Technologies? | Current revenue multiple of UFP Technologies is 3.7x. |
| Is UFP Technologies profitable? | Yes, UFP Technologies is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of UFP Technologies? | UFP Technologies's last 12 months EBITDA is $114M. |
| What is UFP Technologies's EBITDA margin? | UFP Technologies's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of UFP Technologies? | Current EBITDA multiple of UFP Technologies is 17.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
